Clinical trial
Validation of Molecular Prognostic Tests in NSCLC
NCT01517971 is registered in ClinicalTrials.gov with Alliance for Clinical Trials in Oncology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Validation of Molecular Prognostic Tests in NSCLC
- Lead sponsor
- Alliance for Clinical Trials in Oncology
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2012
- Completion date
- February 27, 2019
- Enrollment
- 1,060 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer